ERBB2 and neoplasm: Tumour subtypes of the primary tumour were distributed as following: TNBC 22.3% (n = 197), Luminal A 33.4% (n = 295), Luminal B/HER2 enriched 25.1% (n = 221), HER2 positive 19.2% (n = 169).